Pandemic Influenza Vaccine (Dynavax Technologies)

N/A

Report date: 2025/12/23 16:25:00

Base Information

Drug NamePandemic Influenza Vaccine (Dynavax Technologies)
Drug Alias NamePandemic Influenza Vaccine (H5N1) with CpG1018-adjuvanted (Dynavax Technologies)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesDynavax Technologies Corp
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A